PL430228A1 - Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract - Google Patents

Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract

Info

Publication number
PL430228A1
PL430228A1 PL430228A PL43022819A PL430228A1 PL 430228 A1 PL430228 A1 PL 430228A1 PL 430228 A PL430228 A PL 430228A PL 43022819 A PL43022819 A PL 43022819A PL 430228 A1 PL430228 A1 PL 430228A1
Authority
PL
Poland
Prior art keywords
extract
obtaining
composition containing
kalanchoe
administration
Prior art date
Application number
PL430228A
Other languages
Polish (pl)
Inventor
Sylwia NOWAK
Iwona Nowak
Bartosz Walter
Original Assignee
Nowak Sylwia
Iwona Nowak
Bartosz Walter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowak Sylwia, Iwona Nowak, Bartosz Walter filed Critical Nowak Sylwia
Priority to PL430228A priority Critical patent/PL430228A1/en
Publication of PL430228A1 publication Critical patent/PL430228A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Przedmiotem wynalazku jest sposób otrzymywania ekstraktu z Kalanchoe daigremontiana., ekstrakt, kompozycja zawierająca ekstrakt wytworzony tym sposobem, zastosowanie ekstraktu i postać podawania ekstraktu wytworzonego sposobem.The present invention relates to a method of obtaining an extract of Kalanchoe daigremontiana., An extract, a composition containing the extract produced by this method, the use of the extract, and an administration form of the extract produced by the method.

PL430228A 2019-06-13 2019-06-13 Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract PL430228A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL430228A PL430228A1 (en) 2019-06-13 2019-06-13 Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL430228A PL430228A1 (en) 2019-06-13 2019-06-13 Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract

Publications (1)

Publication Number Publication Date
PL430228A1 true PL430228A1 (en) 2020-12-14

Family

ID=73727746

Family Applications (1)

Application Number Title Priority Date Filing Date
PL430228A PL430228A1 (en) 2019-06-13 2019-06-13 Method of obtaining an extract from Kalanchoe sp., the extract, composition containing this extract, use and form of administration of the extract

Country Status (1)

Country Link
PL (1) PL430228A1 (en)

Similar Documents

Publication Publication Date Title
JOP20220304A1 (en) Steroid 19-nor3,C3- with a C21-N pyrazolyl crystalline double substitution
EA202190983A1 (en) NEW ANTIBODY TO C-KIT
MX2021014441A (en) Tead inhibitors and uses thereof.
MX2021001706A (en) Fused ring compounds.
MX2025001902A (en) Anti-ror antibody constructs
MY209489A (en) Antibody against human il-4ra and use thereof
EA201992177A1 (en) COMPOSITIONS BASED ON NIRAPARIB
ECSP21068097A (en) CLAUDIN 6 ANTIBODIES AND USES THEREOF
MX2023014154A (en) ANTI-CCR8 ANTIBODIES.
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
CY1124338T1 (en) 3-PHOSPHOGLYCERATE DEHYDROGENATION INHIBITORS AND THEIR USES
MY200641A (en) New isoxazolyl ether derivatives as gaba a alpha5 pam
EP4302827A3 (en) Rapamycin analogs and uses thereof
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
MX2021001520A (en) Methods for delaying occurrence of new-onset type 2 diabetes and for slowing progression of and treating type 2 diabetes.
MX2020011986A (en) Compositions comprising glucose and hemicellulose and their use.
MX2020008125A (en) COMPOSITIONS COMPRISING BERBERINE.
MY194682A (en) Formulation
EA201890075A1 (en) INJECTABLE PHARMACEUTICAL COMPOSITIONS LEFAMULIN
SA520420261B1 (en) Ernumab formulations and uses
BR112021020367A2 (en) Solid forms of (e)-3-[2-(2-thienyl)vinyl]-1h-pyrazole
PH12022551570A1 (en) Oral composition with increased sweetness
EA202090971A1 (en) METHODS OF APPLICATION AND COMPOSITIONS CONTAINING DULAGLUTIDE
SG11201900491PA (en) Cement composition, method for producing same, and method for producing fly ash for cement composition
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives